Dashboard
Weak Long Term Fundamental Strength with a -190.09% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 3.54% signifying low profitability per unit of shareholders funds
The company has declared Negative results for the last 3 consecutive quarters
Stock is technically in a Mildly Bearish range
Risky - Negative EBITDA
Despite the size of the company, domestic mutual funds hold only 0% of the company
Stock DNA
Software Products
INR 797 Cr (Micro Cap)
NA (Loss Making)
21
0.00%
-0.53
-2.94%
1.83
Total Returns (Price + Dividend) 
Latest dividend: 3.0000000000000004 per share ex-dividend date: Aug-30-2024
Risk Adjusted Returns v/s 
Returns Beta
News

Quick Heal Technologies Ltd is Rated Strong Sell
Quick Heal Technologies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read More
Quick Heal Technologies Ltd: Technical Momentum Shifts Amid Prolonged Downtrend
Quick Heal Technologies Ltd, a micro-cap player in the software products sector, has experienced a subtle yet notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite this slight improvement, the stock continues to grapple with a prolonged downtrend, reflected in its deteriorating returns and mixed technical indicator signals.
Read More
Quick Heal Technologies Ltd is Rated Strong Sell
Quick Heal Technologies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 10 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Change in Management
16-Nov-2026 | Source : BSEIntimation of Resignation of Mr. Sangamesh S as Head of Seqrite Labs
Announcement under Regulation 30 (LODR)-Change in Management
14-Nov-2026 | Source : BSEIntimation of Resignation of Mr. Sangamesh S as Head of Seqrite Labs
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
05-Nov-2026 | Source : BSEAllotment of 1210 Equity Shares under ESOP Scheme 2021
Corporate Actions 
No Upcoming Board Meetings
Quick Heal Technologies Ltd has declared 30% dividend, ex-date: 30 Aug 24
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.0%)
Held by 9 FIIs (0.4%)
Sanjay Sahebrao Katkar (28.72%)
None
24.13%
Quarterly Results Snapshot (Consolidated) - Sep'26 - YoY
YoY Growth in quarter ended Sep 2026 is -22.26% vs 13.65% in Sep 2025
YoY Growth in quarter ended Sep 2026 is -26.68% vs 90.60% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -2.11% vs 10.77% in Sep 2024
Growth in half year ended Sep 2025 is -70.66% vs 5,742.86% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -0.98% vs 1.26% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 8.69% vs -18.73% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -6.62% vs -4.19% in Mar 2025
YoY Growth in year ended Mar 2026 is -316.87% vs -79.21% in Mar 2025